Abstract: Iodide nanoparticles are provided. The nanoparticles can be potassium iodide (KI) nanoparticles, and can be formed of, a radioisotope, preferably 131I or 125I. The nanoparticles can include a coating that can increase the half-life of the particles, serve as a platform for attachment or entrapment of targeting moieties and/or additional active agents, or a combination thereof. Methods of use are also provided. For example, a method of treating a subject for cancer can including sensitizing the subject to radiation therapy by administrating the iodide nanoparticles to the subject in combination with one or more doses of radiation therapy. Methods of treating or imaging a subject can also include administering the subject an effective amount iodide nanoparticles, without the nanoparticles serving as radiosensitizer. In such methods, the nanoparticles typically include a radioisotope or an anticancer active agent, for example 131I, 125I, 124I, or 123I, or a chemotherapeutic agent.

Abstract: Compositions and methods of improving radiation therapy are provided. The composition typically includes an effective amount of 7-DHC or a derivative or analog thereof. The methods typically include administering the composition to a subject in need thereof in combination with one or more doses of radiation therapy, preferably non-ultraviolet radiation therapy. A preferred radiation is ionizing radiation. The compositions and methods can be used to treat tumors, e.g., benign and malignant tumors. Thus, methods of treating cancer are provided. In preferred embodiments, the 7-DHC or a derivative or analog thereof is encapsulated or incorporated into nanoparticles. The particles can be, for example, polymeric nanoparticles, lipoprotein or lipoprotein-like particles, liposomes, inorganic nanoparticles, or a combination thereof. In some embodiments, the 7-DHC or analog thereof is derivatized with a polymer or saccharide, which is some embodiments, can self-assemble into particles.

Abstract: A control method, apparatus and system for anti-vortex induced vibration of a wind turbine are provided. With the method, it is determined whether the wind turbine enters an anti-vortex induced vibration mode; an anti-vortex induced vibration function and triggering a window period is enabled in response to the wind turbine entering the anti-vortex induced vibration mode; and a blade of the wind turbine is adjusted to a preset anti-vortex induced vibration position in the window period, where the window period indicates a minimum time to complete the anti-vortex induced vibration function.

Abstract: Gd-encapsulated carbonaceous dots (Gd@C-dots) hold great potential in clinical translation as T1 contrast agent for magnetic resonance imaging. Disclosed are methods of using said particles as radiosensitizing agents.

Abstract: A coated cathode material includes a cathode active material and an interfacial layer coating the cathode active material. The interfacial layer includes a lithium-containing fluoride which includes at least one additional metal different from lithium.

Abstract: A memory data migration method, apparatus, and system are provided. During memory migration, data is classified into two parts based on a hot and cold degree of the data. Hot data is directly migrated, and cold data is written into a shared storage device shared by memories. When needing to be used in a destination-end memory, the cold data may be read from the shared storage device. This reduces an amount of data that needs to be migrated to the destination-end memory, thereby improving memory migration efficiency.

Abstract: Disclosed are particles comprising lithium salts and methods for their use in treating inflammatory conditions.

Abstract: A connector is provided including a housing and a terminal set. The housing is a conductor and has a connection end and a fixed end. The terminal set includes a plurality of signal terminals and a plurality of grounding terminals. The plurality of grounding terminals includes at least a first grounding terminal. A length of the first grounding terminal is less than 50% of a length of the longest signal terminal, and the first grounding terminal is directly or indirectly electrically connected to a grounding surface to achieve grounding. The grounding terminal is greatly shortened and is not required to pass through the fixed end to be connected to a printed circuit board (PCB), which greatly alleviates the problem of resonance caused by an excessive length of the grounding terminal and improves quality of signal transmission.

Abstract: A high-frequency signal switching apparatus and a testing apparatus are provided. The switching apparatus comprises at least one switching module comprising a first input port; a second input port; a plurality of output ports; a primary-stage switching element group comprising at least a first primary-stage switch and a second primary-stage switch, and a final-stage switching element group comprising a plurality of final-stage switches; wherein a head-end interface of the first primary-stage switch is electrically connected to the first input port, a head-end interface of the second primary-stage switch is electrically connected to the second input port; and each final-stage switch is optionally electrically connected to the first primary-stage switch, the second primary-stage switch, and two of the plurality of output ports simultaneously, thereby the two output ports being respectively and optionally electrically connected to the first input port and the second input port.

Abstract: A memory data migration method, apparatus, and system are provided. During memory migration, data is classified into two parts based on a hot and cold degree of the data. Hot data is directly migrated, and cold data is written into a shared storage device shared by memories. When needing to be used in a destination-end memory, the cold data may be read from the shared storage device. This reduces an amount of data that needs to be migrated to the destination-end memory, thereby improving memory migration efficiency.

Abstract: Radiosensitizer prodrugs and formulations and methods of use thereof are provided. Typically, the radiosensitizer prodrug is an analog of a radiosensitizer parent compound having one or more S-nitrosothiol moieties. Typically, the S—N bond of the S-nitrosothiol moiety can be cleaved by radiation during radiotherapy, releasing the parent compound and nitric oxide. One or preferably both the parent compound and the nitric oxide can contribute to death of tumor cells exposed to radiotherapy. Nanoparticle formulations for delivery of the prodrug, and methods of using them in combination with radiotherapy to treat tumors and cancer are also provided.

Abstract: An anode includes: (1) a current collector; and (2) an interfacial layer disposed over the current collector. The interfacial layer includes a film of a layered material and a reinforcing material selectively disposed over certain regions of the film, while other regions of the film remain exposed from the reinforcing material.

Abstract: A memory data migration method, apparatus, and system are provided. During memory migration, data is classified into two parts based on a hot and cold degree of the data. Hot data is directly migrated, and cold data is written into a shared storage device shared by memories. When needing to be used in a destination-end memory, the cold data may be read from the shared storage device. This reduces an amount of data that needs to be migrated to the destination-end memory, thereby improving memory migration efficiency.

Abstract: The present invention describes a system and method for selecting and optimizing a sound stimulus using a deep neural network to regulate and improve human sleep quality. The deep neural network has the capability of characterizing processing of human brain cortical neurons for external stimulus (images, sounds, etc.) information. By inputting massive sound stimuli into the deep neural network, a sound mode which causes model-estimated sleep electroencephalograph to be optimal can be found, the sound mode is applied to a real human body, and the intensity of corresponding sleep waves of the human body in different sleep stages is enhanced through closed-loop optimization so as to realize the purpose of regulating sleep. The present invention mainly aims at solving the technical problem of how to select and optimize, when a sound stimulus means (music, speech, natural sounds, white/colored noise, etc.) is used to assist in human sleep.

Abstract: Particles formed from an alkai metal or alkaline earth metal and halide, for example, sodium and chloride, are provided. The particles can have a hydrophilic coating or external layer, formed of, for example, a polyether-lipid conjugate. In preferred embodiments, the lipid is a phospholipid such as a phosphoethanolamine, and the polyether is a polyethylene glycol such as a PEG amine. Methods making the particles by, for example, a microemulsion reaction, are also provided. Pharmaceutical compositions including a plurality of particles and a pharmaceutically acceptable carrier are also disclosed. Typically the compositions include an effective amount of particles to treat a disease or condition, particularly cancer, in a subject in need thereof. The particles are typically nanoparticles, for example, between about 10 nm and 250 nm and can be monodisperse.

Abstract: Disclosed herein are nanoparticles comprising a therapeutic or diagnostic agent positioned within an orthosilicate inner matrix, and a silica outer shell encapsulating the orthosilicate inner matrix. Also disclosed are methods of treating a disease in a subject comprising administering to the subject a biological carrier cell comprising the nanoparticle. Also disclosed are methods of preparing nanoparticles, methods of delivering nanoparticles comprising a therapeutic or diagnostic agent to a target cell, and methods of loading a therapeutic or diagnostic agent into a biological carrier cell.

Abstract: Disclosed are particles comprising lithium salts and methods for their use in treating inflammatory conditions.

Abstract: A system includes a memory buffer, a first data processor, a second data processor, and a controller. The first data processor performs a write operation to write data into the memory buffer and provides a first reference indicating a status or progress of the write operation. The controller provides a second reference indicating a buffer block in the memory buffer. The second data processor receives the first reference and the second reference, uses a threshold and the first reference to determine whether the buffer block contains enough data to be processed by the second data processor, obtains data to be processed from the buffer block using the second reference if the buffer block contains enough data to be processed, and processes the data obtained from the buffer block.